The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Akineton 2mg Tablets



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/010/001

Main Information

Trade NameAkineton 2mg Tablets
Active SubstancesBIPERIDEN HYDROCHLORIDE
Dosage FormTablet
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/010/001

Group Information

ATC CodeN04AA Tertiary amines
N04AA02 biperiden

Status

Authorised/WithdrawnAuthorised
Licence Issued28/07/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back